Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 17, 2020
Finance
Crossovers pile into new rounds for C4, 4D Molecular
...Financial Group, Octagon Investments and QUAD Investment Management. Existing investors joining them were Arrowmark Partners,
Berkeley Catalyst Fund
...
Read More
BioCentury
|
Mar 18, 2020
Finance
March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS
...led by The Column Group with participation by Nextech Invest, ShangPharma, LifeForce Capital, and the
Berkeley Catalyst Fund
...
Read More
BioCentury
|
Sep 7, 2018
Financial News
4D Molecular rises $90M series B
...Financial Group, Pappas Capital & Chiesi Ventures, Perceptive Advisors, Ridgeback Capital Investments, CureDuchenne Ventures and
Berkeley Catalyst Fund
...
Read More
BioCentury
|
Sep 5, 2018
Financial News
4D Molecular raises $90M series B
...Financial Group, Pappas Capital & Chiesi Ventures, Perceptive Advisors, Ridgeback Capital Investments, CureDuchenne Ventures and
Berkeley Catalyst Fund
...
Read More
Items per page:
10
1 - 4 of 4
BioCentury
|
Jun 17, 2020
Finance
Crossovers pile into new rounds for C4, 4D Molecular
...Financial Group, Octagon Investments and QUAD Investment Management. Existing investors joining them were Arrowmark Partners,
Berkeley Catalyst Fund
...
Read More
BioCentury
|
Mar 18, 2020
Finance
March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS
...led by The Column Group with participation by Nextech Invest, ShangPharma, LifeForce Capital, and the
Berkeley Catalyst Fund
...
Read More
BioCentury
|
Sep 7, 2018
Financial News
4D Molecular rises $90M series B
...Financial Group, Pappas Capital & Chiesi Ventures, Perceptive Advisors, Ridgeback Capital Investments, CureDuchenne Ventures and
Berkeley Catalyst Fund
...
Read More
BioCentury
|
Sep 5, 2018
Financial News
4D Molecular raises $90M series B
...Financial Group, Pappas Capital & Chiesi Ventures, Perceptive Advisors, Ridgeback Capital Investments, CureDuchenne Ventures and
Berkeley Catalyst Fund
...
Read More
Items per page:
10
1 - 4 of 4
Previous page
Next page